In sports medicine, the enthesis—a critical tendon-bone junction—poses a costly challenge, with high failure rates demanding innovative solutions.
In the sports medical space, there exists a lingering challenge: the enthesis. This often-overlooked junction between tendon and bone has proven to be a formidable obstacle in the field, contributing to the high failure rates and staggering costs associated with procedures like rotator cuff repairs. With failure rates ranging from 20 to 94% and annual costs surpassing $430 million, it’s clear that a solution is urgently needed.
Enter Tetrous, a pioneering startup aiming to tackle this orthopedic frontier head-on. Their groundbreaking approach revolves around reimagining tendon-bone attachment by focusing on the intricate biology of the enthesis. Unlike traditional methods that result in mechanically inferior scar tissue, Tetrous has developed a game-changing solution that promotes the regeneration of this vital structure. Website – https://tetrous.com/
In the challenging space of sports medicine surgery, where tendon-bone repairs often fail, a pioneering startup is revolutionizing the field with a groundbreaking implant that tac...
Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !

